Brazos Neuroscience key facts
- Developer of a blood-based diagnostic testing tool designed for evaluating mild-to-moderate traumatic brain injuries.
- Notable investors include Audacious Capital.
- Status: Privately Held (backing).
Who backs Brazos Neuroscience
1- ·Watch Brazos Neuroscience: the Monday email on marks, rounds and moves
Brazos Neuroscience funding rounds
1 roundsBrazos Neuroscience investors
1 investor is on record for Brazos Neuroscience, including Audacious Capital. By type, the record holds 1 venture capital firm.
About Brazos Neuroscience
Developer of a blood-based diagnostic testing tool designed for evaluating mild-to-moderate traumatic brain injuries. The company's product analyzes glial and neuronal biomarkers along with genetic indicators to assess injury severity and recovery potential, enabling healthcare providers to diagnose and monitor brain injuries across clinical phases with objective data and personalized treatment decisions.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Bellaire, TX, United States
- Founded
- 2019
- Website
- brazosneuro.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Brazos Neuroscience doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.